End this depression, but how?
- 16 May 2012
In his new book End This Depression Now! Paul Krugman dismantles pro-austerity arguments. But by "treating the initial crisis as an anomaly caused by irresponsible financial behavior," writes Fred Block, he surrenders "the structuralist high ground to right-wing economists." Dissent Magazine
Here's one: JP Morgan "is the creator of credit default swaps – which caused the 2008 financial crisis, and is the asset class which blew up and caused the loss." The Big Picture
Matthew O'Brien says if we want to get serious about inequality, we have to get serious about fixing financial markets that are divorced from any economic fundamentals — or rules. The Atlantic
Key findings from a new paper show that rarely are countries able to cut spending during a slump without suffering from slowed growth or higher debt ratios. Next New Deal
With corporations around the world set to spend some of the nearly $8 trillion in emergency cash they've amassed, Neil Shah reports that this could help nudge the U.S. recovery onto stronger footing-and make it less vulnerable to Europe's troubles and America's own looming fiscal challenges. Real Time Economics
Got any other suggestions for what we should be reading? Tell us below?
Sign up for our free email newsletter here.
- What has happened to food and energy prices and inflation in 2014?
- Both the Bank of England and the UK Public Finances are having a Mad Hatters Tea Party
- Invesco Perpetual's Mark Barnett on where UK equities go from here
- AstraZeneca gets a Pfizer boost
- Mindful Money's weekly share-tips: Sports Direct, Reed Elsevier, Unilever, William Hill and WPP
- Gap between investor income expectations and actual returns widens
- The unanswered question - could new mortgage lending rules restrain house prices - outside London at least?
- Consumer group Fairer Finance calls on banks and insurers to spare their customers the small print
- Despite greater pension freedom retirees are set to see their income collapse
- AstraZeneca shares jump 7% on the back of rumoured Pfizer takeover